Vertex Pharmaceuticals Inc. closed 10.29% short of its 52-week high of $519.88, which the company achieved on November 8th.

The hybrid decentralized exchange has confirmed that it will shut down its platform on Arbitrum and move to Kraken-backed L2 ...

We present an unsupervised method for discovering compound image structures that are comprised of simpler primitive objects. An initial segmentation step produces image regions with homogeneous ...

According to Benzinga Pro, Vertex Pharmaceuticals's peer group average for short interest as a percentage of float is 6.62%, which means the company has less short interest than most of its peers. Did ...

We propose a scalable graph processing hardware accelerator called NOVA that is based on a novel vertex management architecture that decouples the execution of reduction and propagation operations in ...

Ten people have been effectively cured of their type 1 diabetes after a breakthrough infusion of a new treatment on the path ...